Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,745-3,756 of 5,650
Drug study icon
RecruitingNCT07295197

Oral Indicators for ED Screening

This summary needs review. Please check the official study record and contact the research team for details.

In Bologna
Eating disordersOtherFrom 18 Years to 40 Years
Countries
Italy
Sponsor
University of Bologna
Condition
Eating disorders
Drug study icon
RecruitingNCT05809778

Oral Lesions in people with Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Trieste
Eating disordersOtherFrom 10 Years to 18 Years
Countries
Italy
Sponsor
IRCCS Burlo Garofolo
Condition
Eating disorders
Behavioral study icon
RecruitingNCT06854224

Orexin Antagonism for Suicide prevention: A Proof-of-Concept study

This study is looking at whether Suvorexant (dual orexin receptor antagonist) can help people with Suicide prevention or depression. Participants receive a study treatment and complete follow-up visits and assessments.

In The Bronx
Suicidality, DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Marianne Goodman
Condition
Suicidality, Depression
Other study type icon
RecruitingNCT06800898

Orexin Gene in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Oggebbio
Eating disordersOtherOver 18 Years
Countries
Italy
Sponsor
Istituto Auxologico Italiano
Condition
Eating disorders
Drug study icon
RecruitingNCT06444256

Orexin Receptor Antagonism and Sleep in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
AddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Addiction
Drug study icon
RecruitingNCT05630781

Orexin s Role in the Neurobiology of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
AddictionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Addiction
Drug study icon
RecruitingNCT05641623

OSU6162 as add-on in SSRI/SNRI-resistant Depression

This study is looking at care and outcomes for people with Depression, depression, Treatment-Resistant, Depressive Episode, or Recurrent depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Lund
DepressionDrugFrom 25 Years to 65 Years
Countries
Sweden
Sponsor
Göteborg University
Condition
Depression
Drug study icon
RecruitingNCT05296356

OSU6162 in Depression in bipolarity (OBID)

This study is looking at whether OSU6162 can help people with Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Gothenburg
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Sweden
Sponsor
Göteborg University
Condition
Bipolarity, Depression
Behavioral study icon
RecruitingNCT06585709

OUD (Addiction) Target study

This summary needs review. Please check the official study record and contact the research team for details.

In Durham
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Duke University
Condition
Addiction
Behavioral study icon
RecruitingNCT07216326

Our Voices Matter: Intervention for Depression in Youth

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
DepressionBehavioralFrom 15 Years to 20 Years
Countries
United States
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.